These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38106902)

  • 1. Screening of hepatitis B and C viral infection, recognition of risk factors, and immunization of patients against hepatitis B virus: a module developed for effective hepatitis control.
    Ejaz S; Abdullah I; Malik WN; Anjum S; Ashraf M; Akhtar N; Khan A; Hameed Y; Usman M; Cheema U; Sidiq S
    Front Public Health; 2023; 11():1269209. PubMed ID: 38106902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study.
    Hiva S; Negar K; Mohammad-Reza P; Gholam-Reza G; Mohsen A; Ali-Asghar NG; Mohammed-Jafar S
    BMC Public Health; 2020 Jun; 20(1):920. PubMed ID: 32532228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology and associated risk factors of hepatitis B and C virus infections among pregnant women attending maternity wards at two hospitals in Swabi, Khyber Pakhtunkhwa, Pakistan.
    Israr M; Ali F; Nawaz A; Idrees M; Khattak A; Ur Rehman S; Azizullah A; Ahmad B; Bano SA; Iqbal R
    PLoS One; 2021; 16(8):e0255189. PubMed ID: 34415906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.
    Ashraf H; Alam NH; Rothermundt C; Brooks A; Bardhan P; Hossain L; Salam MA; Hassan MS; Beglinger C; Gyr N
    BMC Infect Dis; 2010 Jul; 10():208. PubMed ID: 20630111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
    Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
    PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B among University Population: Prevalence, Associated Risk Factors, Knowledge Assessment, and Treatment Management.
    Kazmi SA; Rauf A; Alshahrani MM; Awadh AAA; Iqbal Z; Soltane R; Tag-Eldin E; Ahmad A; Ansari Z; Zia-Ur-Rehman
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146743
    [No Abstract]   [Full Text] [Related]  

  • 8. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B and C: Seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia.
    Demsiss W; Seid A; Fiseha T
    PLoS One; 2018; 13(5):e0196539. PubMed ID: 29763447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency distribution and risk factors of hepatitis B virus and hepatitis C virus infections among thalassemia patients: a regional study.
    Shah T; Hussain W; Ali N; Sardar S; Ishaq M; Ur Rahman M; Ding L; Qayyum S; Khan I
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):248-252. PubMed ID: 30358571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B-C and human immunodeficiency virus: seroprevalence and associated factors among health students in Saudi Arabia.
    AlShamlan NA; Al Shammari MA
    Hosp Pract (1995); 2021 Aug; 49(3):221-228. PubMed ID: 33663301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
    Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
    Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vietnamese community screening for hepatitis B virus and hepatitis C virus.
    Kallman JB; Tran S; Arsalla A; Haddad D; Stepanova M; Fang Y; Wrobel VJ; Srishord M; Younossi ZM
    J Viral Hepat; 2011 Jan; 18(1):70-6. PubMed ID: 20196807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H
    J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotropic viruses (hepatitis A, B, C, D and E) in a rural Brazilian population: prevalence, genotypes, risk factors and vaccination.
    Caetano KAA; Bergamaschi FPR; Carneiro MAS; Pinheiro RS; Araújo LA; Matos MA; Carvalho PMRS; de Souza MM; de Matos MAD; Del-Rios NHA; Martins RMB; Motta-Castro ARC; Soares CC; Cook RL; Teles SA
    Trans R Soc Trop Med Hyg; 2020 Feb; 114(2):91-98. PubMed ID: 31608957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Risk Factors Associated with Hepatitis B and C in Nawabshah, Sindh, Pakistan.
    Samo AA; Laghari ZA; Baig NM; Khoso GM
    Am J Trop Med Hyg; 2020 Dec; 104(3):1101-1105. PubMed ID: 33350368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
    Hatzakis A; Wait S; Bruix J; Buti M; Carballo M; Cavaleri M; Colombo M; Delarocque-Astagneau E; Dusheiko G; Esmat G; Esteban R; Goldberg D; Gore C; Lok AS; Manns M; Marcellin P; Papatheodoridis G; Peterle A; Prati D; Piorkowsky N; Rizzetto M; Roudot-Thoraval F; Soriano V; Thomas HC; Thursz M; Valla D; van Damme P; Veldhuijzen IK; Wedemeyer H; Wiessing L; Zanetti AR; Janssen HL
    J Viral Hepat; 2011 Sep; 18 Suppl 1():1-16. PubMed ID: 21824223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus infection among different sex and age groups in Pakistani Punjab.
    Khan F; Shams S; Qureshi ID; Israr M; Khan H; Sarwar MT; Ilyas M
    Virol J; 2011 May; 8():225. PubMed ID: 21569532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and C virus infection in Crohn's disease.
    Biancone L; Pavia M; Del Vecchio Blanco G; D'Incà R; Castiglione F; De Nigris F; Doldo P; Cosco F; Vavassori P; Bresci GP; Arrigoni A; Cadau G; Monteleone I; Rispo A; Fries W; Mallardi B; Sturniolo GC; Pallone F;
    Inflamm Bowel Dis; 2001 Nov; 7(4):287-94. PubMed ID: 11720317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study.
    Acikgoz A; Cimrin D; Kizildag S; Esen N; Balci P; Sayiner AA
    BMC Infect Dis; 2020 Jul; 20(1):529. PubMed ID: 32698841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.